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Rationale: While exercise capacity, expressed as maximal oxygen consumption (VO2max),
has been proposed to be the best predictor of postoperative cardiopulmonary complica-
tions after surgical resection in lung cancer patients, the literature remains controversial.
The purpose of this study was to use the meta-analytic approach to determine if VO2max,
expressed as either ml kg1min1 or as a percentage of predicted, differed between
patients who develop postoperative cardiopulmonary complications versus those that do
not.
Methods: Studies were retrieved via (1) computerized literature searches, (2) cross
referencing from retrieved articles, and (3) expert review of our reference list. Trials were
included if they reported preoperative VO2max values (ml kg
1min1 or percentage of
predicted) and had patients in which postoperative cardiopulmonary complications
occurred.
Results: Fourteen studies representing a total of 955 men and women met our criteria for
inclusion. Across all designs and categories, random-effects modeling demonstrated that
patients without postoperative pulmonary complications had significantly higher levels of
VO2max in ml kg
1min1 (mean difference ¼ 3.0, 95% confidence interval (CI), 1.9–4.0) as
well as VO2max as a percentage of predicted (mean difference ¼ 8, 95% CI, 3.3–12.8).
Conclusion: After a systematic review of the literature, we found that exercise capacity,
expressed as VO2max, is lower in patients that develop clinically relevant complications
after curative lung resection. These results are important for the practicing clinicianElsevier Ltd. All rights reserved.
ulmonary & Critical Care Medicine, University of Pittsburgh, 3471 5th Avenue, Suite 1211 Kaufmann
: +1 412 692 2352; fax: +1 412 648 6495.
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Lung resection and exercise capacity 1791because they answer the literature controversy on the usefulness of measuring
preoperative exercise capacity and reinforce the current guidelines on decision making
for lung resection.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Lung resection is the only curative treatment for lung
cancer. In almost every case, an effort is made to provide a
curative surgical resection. While outcomes from lung
resection have improved over the years, there is still a high
rate of morbidity and mortality as a result of postoperative
cardiopulmonary complications (PPC).1–3
PPC include (1) respiratory failure (acute respiratory
distress syndrome (ARDS), prolonged postoperative mechan-
ical ventilation, or reintubation), (2) pneumonia, (3)
atelectasis requiring bronchoscopy, (4) myocardial infarc-
tion, and (5) arrhythmias requiring intravenous treatment.
Several studies which have found that exercise capacity is
the best predictor of PPC have also proposed specific cut
points for maximal oxygen consumption (VO2max) that
discriminate whether patients will develop PPC.1,3–7 This is
usually displayed using Receiver Operating Characteristic
(ROC) curves from large studies. In addition, exercise
capacity is included in an algorithm for deciding whether
patients with borderline lung function should undergo
thoracic surgery.8,9
While the previously mentioned studies have found that
exercise capacity is a strong predictor of PPC, others have
not.10–12 Given the controversy between the aforementioned
studies, a need exists to examine whether exercise capacity, as
measured by VO2max from an incremental test, differs between
those patients that develop PPC and those patients that do not
develop PPC when systematically combining all published
literature. We performed the following meta-analysis to
address this clinically relevant controversy.
Methods
Data sources
We searched MEDLINE (March 1, 1966–February 28, 2005)
and EMBASE (March 1974–February 2005) using the terms
lung/surgery, lung resection/cancer, bronchogenic carcino-
ma, thoracotomy, pneumonectomy, exercise test, and post-
operative pulmonary complications. We augmented our
search by reviewing the reference lists of retrieved articles,
including review articles, as well as the reference lists of
related articles in our files. A medical librarian performed an
independent search to ensure completeness. The search was
not limited to English language studies but was limited to
published reports.
Study identification and eligibility
We attempted to identify all published studies that used
VO2max to determine exercise capacity in the immediate
preoperative period prior to lung resection and documentedcardiopulmonary complications in the first 30 days after
surgery. To be included in the analysis, studies had to have
(1) a maximal exercise test during the preoperative period
prior to lung resection for lung cancer; (2) reported VO2max
in the form of % predicted, ml kg1min1 or liters per
minute; (3) defined PPC as one or more of the following:
atelectasis requiring bronchoscopy, respiratory failure,
prolonged mechanical ventilation, and pneumonia docu-
mented by objective criteria that include chest X-ray and
laboratory values and symptoms; (4) provided data on the
physiologic characteristics of the two groups, i.e., those
with and without PPC.
The reason for choosing specific postoperative pulmonary
complications in this study is because of their clinical
meaningfulness and the way (almost uniformly) those
complications were presented in the publications reviewed.
The manuscripts that entered the meta-analysis presented
the two groups: complicated patients and uncomplicated
patients (control) with their respective measurements and
outcomes which made the analysis possible.
Data extraction
Two people independently coded the studies. Disagreements
were resolved by consensus.
Data synthesis
The two primary outcomes in this study were VO2max in
ml kg1min1 and VO2max as a percentage of predicted.
These were calculated by taking the difference in pre-
operative exercise capacity between the group that had PPC
and the group that did not have PPC (mean value differences
of the group without PPC minus the group with PPC). Pooled
differences using the original metric were calculated by
assigning weights equal to the inverse of the variance for the
net changes in VO2max. Ninety-five percent confidence
intervals (CI) were generated around the mean treatment
effect to establish statistical significance. We used the
Dersimonian and Laird random-effects model for all ana-
lyses.13 Heterogeneity (variation in study outcomes between
studies), based on a fixed-effects model, was assessed using
Cochran’s Q statistic.14 In addition, we used the recently
developed I2 statistic to determine the percentage of total
variation across the studies due to heterogeneity.15 Gen-
erally, I2 values of 25%, 50%, and 75% are considered to be
indicative of small, moderate, and large amounts of
heterogeneity.15 Publication bias was examined using the
regression approach of Egger et al.15 In addition, sensitivity
analysis was performed with each study deleted from the
model once in order to assess the impact of each study on
our overall results. We explored possible reasons for
heterogeneity by conducting subgroup analysis with the
ARTICLE IN PRESS
R. Benzo et al.1792following types of studies deleted from the model: (1)
studies that did not use cycle ergometers, (2) studies more
than 15 years old, and (3) studies that had fewer than 40
subjects. All data were analyzed using SPSS (version 13.0)16
and Stata/SE 8.2.17 Given the design of the study there was
no patient consenting or Review Board approval.Results
Study selection results and study characteristics
A flow diagram for the selection of studies is shown in Fig. 1.
As can be seen, of the 329 studies initially identified, 14
(4%), representing a total of 955 subjects, met our criteria
for inclusion. A general description of the included studies is
shown in Table 1. All studies were published in refereed
journals. Of the 14 studies included in the analysis, all 14
provided adequate data for VO2max in ml kg
1min1 while 11
provided data for VO2max as a % of predicted.Exercise assessment characteristics
Two studies reported the assessment of exercise using
treadmills12,18 one study used stair climbing,19 while all
others used a cycle ergometer.1,3–7,10,11,20–22Potentially relevant repor
Duplicate reports excluded (n = 172)
Reports screened on
and abs
(n = 15
Reports excluded on the basis of title  
and abstract (n =105) 
Outcome of interest not reported: 12
Disease process other than lung cancer: 93
Full report retrieved for
(n = 5
Reviews:11 
Overlapping data with other selected study:  2 
PPCs or VO2 max not measured or reported: 22 
Unable to obtain records from authors: 3
Figure 1 Flow diagramDifferences in primary outcomes
VO2max in ml kg
1min1
Differences in VO2max in ml kg
1min1 for each study are
shown in Table 2 and Fig. 2 while overall differences are
shown in Table 3. As can be seen, subjects with no PPC had
significantly higher levels of VO2max in ml kg
1min1 when
compared to subjects with PPC. This was equivalent to an
absolute difference of approximately 3ml kg1min1. Sta-
tistically significant and moderate heterogeneity was ob-
served. No statistically significant publication bias was
observed (p40.05). With each study deleted from the
model once, results remained statistically significant. In
addition, we also explored potential sources of heteroge-
neity with the following types of studies deleted from the
model: (1) studies that did not use cycle ergometers, (2)
studies more than 15 years old, and (3) studies that had
fewer than 40 subjects. However, no statistically significant
differences were observed for any of these analyses
(p40.05 for all).VO2max (% predicted)
Differences in VO2max as a percentage of predicted for each
study is shown in Table 2 and Fig. 3 while overall differences
are shown in Table 3. As can be seen, subjects with no PPC
had significantly higher levels of VO2max as a percentage of
predicted when compared to subjects with PPC. Statistically
significant and moderate heterogeneity was observed forts identified (n = 329)
 the basis of title  
tract 
7)
 detailed evaluation 
2)
Reports included in meta-analysis (n=14)
of study selection.
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publication bias was observed (p40.05). With each study
deleted from the model once, results remained statistically
significant. However, when we performed our analysis with
the study by Bolliger et al., deleted from the model,1 no
statistically significant heterogeneity was observed
(p40.05). No statistically significant differences were
observed when the following types of studies were deleted
from the model: (1) studies that did not use cycle
ergometers, (2) studies more than 15 years old, and (3)
studies that had fewer than 40 subjects (p40.05 for all).
Secondary outcomes
Age
Differences in age are shown in Table 3. As can be seen,
subjects without PPC were approximately 4 years youngerTable 1 Characteristics of included studies.
Study (Ref. no.) Subjects Cr
Bechard and
Wetstein6
50 men, (12 WR, 28 L, 10 P) for
diagnosed or suspected lung
carcinoma
Ac
ar
de
Bolliger et al.1 57 men and 23 women (14 WR, 45 L,
21 P); 62 had clinically resectable
malignancies, 12 benign disorders, 6
carcinoid tumors
PC
m
Boysen et al.12 15 men and 2 women (7 WR, 8 L, 2
P); known or suspected lung cancer
Pa
4
da
Brunelli et al.19 128 men, 32 women (21 WR, 111L,
28P); non-small-cell lung carcinoma
Re
pn
ca
Brutsche et al.4 101 men and 24 women (36 WR, 91 L,
18 P); lung cancer
Pa
MI
Epstein et al.20 41 men, 1 woman with lung cancer MI
ve
Richter Larsen
et al.7
97 patients with bronchogenic
carcinoma (18 T, 52 L, 27 P)
Pr
ro
Markos et al.10 53 men and women; with suspected
lung malignancy (6 T, 29 L, 18 P)
De
isc
Morice et al.21 7 men and 1 woman; pulmonary
lesion consistent with clinical stage
1 lung cancer (4 L, 4 WR)
Me
at
Smith et al.5 19 men and 3 women; suspected or
diagnosed lung cancer (5 T, 1 WR, 12
L, 4 P)
Re
4
Torchio et al.18 48 men, 8 women (3 T, 28 L, 23 P) De
Villani and
Busia22
141 men 9 women, lung carcinoma
(procedure not reported)
Re
pn
Wang et al.11 29 men, 11 women; 35 had non-small
cell lung cancer, 5 had other reasons
for thoracotomy (9 WR, 31 L)
Ve
PC
de
Wang et al.3 57 men and women; non-small cell
lung cancer (3 T, 10 WR, 34 L, 10 P)
Ve
at
Notes: FEV1, forced expiratory volume (l); W, watts; mph, miles per
testing; PE, pulmonary embolism; CO2, carbon dioxide; PCO2, partia
gastrointestinal; ICU, intensive care unit; CCU, coronary care unit; O
rate; MI, myocardial infarction; WR, wedge resections; L, lobectomythan subjects with PPC. Moderate but statistically significant
heterogeneity was found.
Peak watts (Wp)
Differences in Wp are shown in Table 3. Those subjects
without PPC had Wp values that were significantly higher
than those with PPC. This was equivalent to difference of 12
watts in favor of subjects without PPC. No statistically
significant heterogeneity was found nor was any statistically
significant publication bias observed (p40.05). With each
study deleted from the model once results remained
statistically significant.
FEV1 (% predicted)
Differences in FEV1 as a percentage of predicted are shown
in Table 3. When compared to subjects with PPC, statisti-
cally significant and higher FEV1 values were found in thoseiteria for complications
ute CO2 retention, prolonged mechanical ventilation,
rhythmia, MI, pneumonia, purulent sputum, PE, atelectasis,
ath
O2445, mechanical ventilation448 h, cardiac arrhythmias,
yocardial infarction, pneumonia, PE, atelectasis, death
CO2445mmHg, arrhythmia, need for mechanical ventilation
48 h postop, MI, pneumonia, PE, atelectasis, death withn 30
ys
spiratory failure requiring mechanical ventilation 448 h,
eumonia, atelectasis, pulmonary edema, PE, MI, arrhythmia,
rdiac failure, death
CO2445mmHg, prolonged mech. ventilation, arrhythmia,
, pneumonia, PE, atelectasis, death
, unstable angina, CHF, arrhythmia, reintubation prolonged
ntilation, pneumonia, atelectasis, high PaCO2, PE, death
olonged mechanical ventilation, PO2o55 or PCO2465 at
om air, MI, pneumonia, arrhythmia, heart failure, death
ath, respiratory failure, pneumonia, atelectasis, PE, MI, or
hemia, arrhythmia, admission to ICU or CCU
chanical ventilation448 h, MI, arrhythmia, pneumonia,
electasis, PE, death
spiratory failure (PaCO2445), mechanical ventilation
48 h, MI, arrhythmia, pneumonia, atelectasis, PE, death
ath, respiratory insufficiency with intubation for 48 h, PE
spiratory failure requiring O2, atelectasis, arrhythmia,
eumonia, ARDS, PE, death
ntilation 424 h, reintubation for respiratory failure,
O2445, pneumonia, atelectasis, need for O2 at discharge,
ath
ntilatory support 448 h, reintubation, PE, pneumonia,
electasis, respiratory insufficiency (PCO2445), death
hour; kpm, kilometers per hour; CPET, cardiopulmonary exercise
l pressure of carbon dioxide; mmHg, millimeters of mercury; GI,
2, oxygen; ARDS, adult respiratory distress syndrome; HR, heart
; P, pneumonectomy; T, thoracotomy.
ARTICLE IN PRESS
Table 2 Primary outcomes for each study.
Study (Ref. no.) N PPC (%) VO2max (ml kg
1min1) VO2max (% predicted)
No PPC PPC No PPC PPC
Bechard and Wetstein6 50 14 17(2) 9.9(9) NA NA
Bolliger et al.1 80 20 19(5) 14(3) 84(19) 61(11)
Boysen wt al.12 17 12 20(5) 16(3) 62(12) 60(3)
Brunelli et al.19 160 14 25(4) 23(4) 111(22) 113(20)
Brustche et al.4 125 25 22(5) 17(5) 78(20) 66(20)
Epstein et al.20 42 33 16(4) 16(5) NA NA
Richter Larsen et al.7 97 32 19(4) 18(4) 84(17) 77(20)
Markos et al.10 53 30 17(6) 16(6) 69(20) 75(28)
Morice et al.21 8 25 17(2) 15(0.7) 67(10) 62(9)
Smith et al.5 22 50 22(4) 14(2) 73(17) 55(9)
Torchio et al.18 54 51 23(4) 19(1) 95(19) 89(7)
Villani and Busia22 150 29 21(4) 19(3) 75(13) 71(11)
Wang et al.11 40 33 17(4) 16(4) NA NA
Wang et al.3 57 33 19(4) 15(2) 70(13) 57(14)
Overall X¯ (SD) 955 28(11) 20(2) 16(3) 80(13) 72(13)
Note: N, number of patients in the study; X¯(SD), mean7standard deviation; %PPC, percentage of patients in the study that developed
postoperative pulmonary complications; PPC, postoperative pulmonary complications; NA, not available.
-15 -10 -5 0 5 10 15
Study
Mean difference 
(95% CI)
Bechard et al (1987) 7.06 ( 0.20, 13.92) 1.9 
 Bolliger et al (1995) 5.00 ( 3.09, 6.91) 8.9 
 Boysen (1990) 3.68 (-2.20, 9.56) 2.4 
Brunelli (2002) 2.25 ( 0.42, 4.08) 9.2 
Brutsche (2000) 4.20 ( 2.01, 6.39) 8.1 
Epstein (1993) 0.30 (-2.86, 3.46) 5.8 
Larsen (1997) 1.24 (-0.59, 3.07) 9.1 
Markos (1989) 0.69 (-2.90, 4.28) 5.0 
Morice (1992) 1.50 (-0.45, 3.45) 8.8 
Smith (1984) 7.50 ( 4.24, 10.76) 5.6 
Torchio et al (1998) 4.45 ( 2.62, 6.28) 9.2 
 Villani (2004) 1.60 ( 0.19, 3.01) 10.4
Wang(1999) 1.60 (-1.34, 4.54) 6.2 
Wang(2000) 4.20 ( 2.46, 5.94) 9.4 
Overall 3.00 ( 1.98, 4.01) 100.0 
Favors Complications            Favors No Complications
Changes in VO2 max (ml/kg/min)
% Weight
Figure 2 Forest plot for changes in VO2max in ml kg
1min1 using a random-effects model. The black boxes, sized relative to
random-effects weighting, represent the mean change in VO2max in ml kg
1min1 for each study while the lines represent the 95%
confidence intervals. The diamond and dashed lines represent the overall mean change in VO2max in ml kg
1min1 across all listed
studies while the left and right ends of the diamond represent the 95% confidence interval for all studies combined.
R. Benzo et al.1794subjects that did not have PPC. No statistically significant
heterogeneity was observed. With each study deleted from
the model once, results remained statistically significant. No
statistically significant publication bias was found (p40.05).DLCO (% predicted)
Differences in DLCO as a percentage of predicted are shown
in Table 3. As can be seen, DLCO values were higher in
patients without PPC versus those with PPC. Statistically
ARTICLE IN PRESS
Table 3 Weighted differences in primary and secondary outcomes.
Variable N NPPC, X¯(SD) PPC, X¯(SD) RE model, X¯(95% CI) Q(p value) I2 (%)
Primary outcomes
VO2max (ml kg
1min1) 14 20.0(2.7) 16.8(3.1) 3.0(2.0–4.1)* 34.9(o0.001)* 62
VO2max (% predicted) 11 80.9(13.8) 72.9(17.6) 8.1(3.3–12.8)* 35.1(o0.001)* 72
Secondary outcomes
Age (years) 12 61.0(3.9) 65.4(4.9) 3.9(6.3 to 1.5)* 25.0(0.007)* 56
Peak watts (Wp) 9 110(22.0) 97(16.0) 13.4(7.1–19.7)* 12.0(0.15) 33
FEV1 (% predicted) 11 78(13.0) 72(10.0) 4.8(1.6–8.1)* 13.8(0.18) 27
DLCO (% predicted) 10 77(11.0) 69(11.0) 9.4(2.6–16.1)* 24.2(0.003)* 62
Notes: N, number of studies; NPPC, no postoperative pulmonary complications; PPC, postoperative pulmonary complications; RE,
random-effects model; Q, heterogeneity statistic based on the fixed-effects model; p, alpha value for Q; I2, percentage of
heterogeneity, calculated as (Qdf)/Q; X¯(SD), mean7standard deviation; X¯(95% CI), mean and 95% confidence interval for the mean;
VO2max, maximum oxygen consumption; FEV1, functional expiratory volume; DLCO, diffusing lung capacity; *, statistically significant;
differences between NPPC and PPC for RE model weighted.
-30 -20 -10 0 10 20 30
Study
Bolliger et al (1995)
Boysen (1990)
Brunelli (2002)
Brutsche (2000)
Larsen (1997)
Markos (1989)
Morice (1992)
Smith (1984)
Torchio et al (1998)
Villani (2004)
Wang (2000)
Overall
Mean  difference 
(95% CI)
23.0 ( 15.9, 30.1) 
1.8 (-6.4,  9.9) 
-1.5 (-10.6,  7.6)
12.0 (  3.9, 20.1)
7.0 (-1.3, 15.3) 
-6.7 (-22.4,  9.0)
4.5 (-11.3, 20.4) 
18.5 (6.4, 30.6)
6.1 (-1.9, 14.1)
4.6 (0.3,  8.9) 
13.0 (5.5, 20.5)
8.1 (3.3, 12.8) 
% Weight
10.5
9.8
9.2
9.8
9.7
5.5
5.5
7.3
9.9
12.4
10.3
100.0
 Favors Complications  Favors No Complications
 Changes in VO2 max (% predicted)
Figure 3 Forest plot for changes in VO2max (% predicted) using a random-effects model. The black boxes, sized relative to random-
effects weighting, represent the mean change in VO2max (% predicted) for each study while the lines represent the 95% confidence
intervals. The diamond and dashed lines represent the overall mean change in VO2max (% predicted) across all listed studies while the
left and right ends of the diamond represent the 95% confidence interval for all studies combined.
Lung resection and exercise capacity 1795significant and moderate heterogeneity was observed for
differences in DLCO between the two groups. With each
study deleted from the model once, results remained
statistically significant. No statistically significant publica-
tion bias was found (p40.05).Discussion
The overall results of this meta-analysis show that exercise
capacity is lower in patients who developed PPC compared
to those that did not. From a clinical perspective, webelieve our results are clinically important because they
clarify the controversy in the existing literature.
Although exercise capacity is a significant predictor of
different outcomes for COPD,23,24 its ability to predict
cardiopulmonary complications in lung cancer resection
patients (often carrying the diagnosis of COPD) has been
controversial. It is in this kind of situation where pooled
estimates from combinable studies, i.e., meta-analysis, can
help identify whether any differences exist. In our study, we
found that higher exercise capacity was associated with
fewer PPC. Given the intent of our meta-analysis, it was not
surprising that no randomized controlled trials (RCT) on this
topic could be located since a randomized design is not
ARTICLE IN PRESS
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studies which tend to have more heterogeneity (variation in
study outcomes between studies) than RCT.25
While the random-effects model controls for statistically
significant heterogeneity, we also examined for heteroge-
neity using the fixed-effects model (Table 3). As a result, we
found statistically significant heterogeneity for both VO2max
in ml kg1min1 as well as VO2max as a percentage of
predicted. While we could not identify any potential sources
of heterogeneity for VO2max in ml kg
1min1, we did find
that the results became homogeneous for VO2max as a
percentage of predicted when the study by Bolliger et al.1
was deleted from the model. That study found a higher
difference in exercise capacity between patients with and
without PPCs. We believe that our results are valid despite
the fact that we could not explain all heterogeneity. In
addition, it is important to realize that both our random-
and fixed-effects analyses yielded similar and statistically
significant differences for all of our reported outcomes
(indicating the stability of the finding). These results
support the notion that exercise capacity is greater in
patients without PPC.
The mean VO2max in ml kg
1min1 of 20ml kg1min1
across all studies (Table 2) for non-complicated patients is
consistent with the threshold proposed for patients with no
risk of complications.5,6,18 The mean value for complicated
patients (Table 2) is also consistent with the currently
proposed threshold for increased risk of 15 VO2max in
ml kg1min1.3,5,9 Our findings support the currently pro-
posed thresholds that are based on individual studies with
smaller number of patients.
The analysis of FEV1 and DLCO also showed significant
differences between the two groups. However this finding
should not be viewed as those two variables being good
predictors of complications. After the extensive search
performed, we found that FEV1 is not consistently reported
as an independent predictor of PPC. In addition, the
difference found in FEV1 between the complicated and
uncomplicated groups (4%) (Table 3) is unlikely to be
clinically meaningful. DLCO has been shown to be an
independent predictor of PPC but in a minority of the
publications.3,11 FEV1 and DLCO are currently used as
screening methods to detect patients with increased risk
of complications but once the patients with increased risk
are defined, an exercise capacity measurement is needed to
further improve the risk assessment.8,9
We believe that our results best reflect the evidence that
currently exists regarding differences in exercise capacity
between patients with PPC versus those without PPC. The
former notwithstanding, we acknowledge that a meta-
analysis of individual patient data (IPD) might have been
more appropriate since it permits the generation of ROC
analysis that can provide cut points in the desired outcome
that discriminates the population that developed complica-
tions from the one that did not. However, given the difficulty
in retrieving IPD from investigators26 we chose to conduct a
summary means meta-analysis. In addition, some studies
had to be excluded because of the different criteria they
used for PPC. Thus, this may be viewed as potential bias.
However, even when those studies were included, they had
no effect on any of our findings (results not shown). Our
results using the original metric for our principal outcomesand also for the other outcomes variables (VO2max in
ml kg1min1, VO2max as a percentage of predicted, Wp,
FEV1, and DLCO) facilitate interpretability
27 and suggest
clinically important differences since those differences are
anchored to clinically meaningful events (PPC). The ‘‘anchor
method’’ is used to define the minimal clinically important
difference in an outcome, by establishing the difference in
that outcome is associated with a clinically meaningful
event.28 For example, the 13Wp difference we found
approximates the 10Wp cut-point considered by experts as
well as reports from clinical trials as the minimally clinically
important difference for that parameter.29 Finally we
recognize that while cardiopulmonary complications are
clinically important, surgery still remains the best opportu-
nity for cure. Most would accept even severe complications
for a chance at long-term survival. With knowledge of
differences that separate groups with different prognoses,
interventions can be directed to overcome that difference
and improve patients’ prognoses. Since low exercise
capacity is a potentially modifiable risk factor, we posit
that an intervention that improves exercise capacity, like
pulmonary rehabilitation, could improve patient outcome
(fewer or no PPC). The National Cancer Institute is currently
funding a study to address that hypothesis.30 Also the
National Emphysema Treatment Trial clearly showed that in
some patients, exercise capacity improved sufficiently after
rehabilitation to change the risk category of the patients.29
In summary, our results suggest, after reviewing all
available literature, that exercise capacity, measured as
VO2max, is lower in patients that develop clinically relevant
PPC after curative lung resection. This study is useful for the
practicing clinician as it reinforces the current guidelines
addressing the importance of assessing exercise capacity as
part of the decision-making process for the surgical
treatment of lung cancer.
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